Working Together
What our partners say
We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us.
-
Our Partners: Bioharmony Therapeutics
What Our Partners Say
Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.
-
Our Partners: Harvard Fibrosis Network
What Our Partners Say
Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
-
Our Partners: Dicerna Pharmaceuticals
What Our Partners Say
-
What Our Partners Say
Jon Weidanz, Chief Scientific Officer AbeXXa Biologics Inc., talks about re-imagining cancer immunotherapy and what makes a good partnership.
-
Our Partners: Hydra BioSciences
What Our Partners Say
Russell Herndon, CEO & President, talks about partnering with BI on novel areas of science in CNS and CardioMetabolic diseases.